Sees FY24 adjusted EBITDA roughly $36M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on STAA:
- Is STAA a Buy, Before Earnings?
- Staar Surgical announces strategic pact in U.S. with SharpeVision, no terms
- Staar Surgical price target lowered to $31 from $33 at Canaccord
- Fly Insider: Athira Pharma, Microstrategy among week’s notable insider trades
- Staar Surgical sees FY24 revenue $335M -$340M, consensus $366.8M